Pharmaceutical Research And Manufacturers Of America

Phrma

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 530241211 ✦ Washington, DC ✦ Designated as a 501(c)(6)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is Pharmaceutical Research And Manufacturers Of America?

Pharmaceutical Research and Manufacturers of America (PHRMA) is a nonprofit organization headquartered in Washington, D.C., with a workforce of 302 employees. Their primary objective is to advocate for public policies that encourage the discovery and development of new medicines by biopharmaceutical research companies. They achieve this by representing their member companies before governmental and regulatory bodies both in the United States and globally. Specifically, PHRMA advocates for patient access to safe and effective medicines through a free market, strong intellectual property incentives, and transparent, efficient regulation.


Official website here: www.phrma.org

What are the reviews and ratings of this charity?

Pharmaceutical Research And Manufacturers Of America is not currently rated by Charity Navigator. The lack of a rating is not indicative of a positive or negative assessment; it merely reflects the organization's ineligibility under current evaluation criteria. Charity Navigator primarily evaluates 501(c)(3) nonprofits, while this organization does not fall under that category, limiting the application of standard rating methods such as Accountability & Finance or Impact & Measurement.

Without a 501(c)(3) status or Form 990 data, Pharmaceutical Research And Manufacturers Of America cannot be assessed through methodologies like Leadership & Adaptability or Culture & Community. Historical data focused on different criteria, which do not fully apply to the current methodology requirements. As such, while financial metrics and leadership details remain unspecified, it's crucial to note this absence doesn't inherently suggest a deficiency or excellence in those areas.

No user reviews are available from GreatNonprofits to provide additional insight into the organization's operational effectiveness or community impact from a user perspective.


This AI summary has been generated from information found on Charity Navigator.

Is Pharmaceutical Research And Manufacturers Of America legitimate?

Pharmaceutical Research And Manufacturers Of America is a legitimate nonprofit organization registered as a 501(c)(6) entity. Pharmaceutical Research And Manufacturers Of America submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $21,453,868
Professional Fundraising Fees: $0
Other Salaries and Wages: $68,715,438

For more financial information, click here


Official website here: www.phrma.org

What is the mission statement of Pharmaceutical Research And Manufacturers Of America?

Pharmaceutical Research and Manufacturers of America (PHRMA) is an organization dedicated to advocating for public policies that encourage the discovery of new medicines for patients by biopharmaceutical research companies. Through effective advocacy efforts, PHRMA works on behalf of its member companies to influence governmental and regulatory bodies, promoting policies that support patient access to safe and effective medicines. PHRMA advocates for a free market without government price controls, strong intellectual property incentives, and transparent, efficient regulation. Their mission is to ensure that patients have access to the latest treatments and innovations in healthcare.


Official website here: www.phrma.org

Who is the CEO of Pharmaceutical Research And Manufacturers Of America?

Stephen J Ubl is the CEO of Pharmaceutical Research And Manufacturers Of America The CEO's salary of Pharmaceutical Research And Manufacturers Of America is $5,053,582 and their total compensation is $6,707,444.


Official website here: www.phrma.org

What is the revenue of Pharmaceutical Research And Manufacturers Of America?

Pharmaceutical Research And Manufacturers Of America's revenue in 2023 was $483,040,082.


Official website here: www.phrma.org

Who are the executives of Pharmaceutical Research And Manufacturers Of America and what are their salaries?

The average compensation at Pharmaceutical Research And Manufacturers Of America during 2023 was $305,659. There are 295 employees and 2759 volunteers at Pharmaceutical Research And Manufacturers Of America.

Here are 47 key members and their salaries (Pharmaceutical Research And Manufacturers Of America's CEO's salary is $5,053,582 and their total compensation is $6,707,444):


Stephen J Ubl (President & Ceo)
  • Compensation: $5,053,582
  • Related: $0
  • Other: $1,653,862
Lori Reilly (Coo)
  • Compensation: $2,233,732
  • Related: $0
  • Other: $656,619
Jennifer Bryant (Evp, Policy/Research)
  • Compensation: $2,471,035
  • Related: $0
  • Other: $75,301
James C Stansel (Gen Counsel & Evp Law, Secy)
  • Compensation: $1,658,117
  • Related: $0
  • Other: $540,693
Anne Esposito (Svp, Federal Advocacy)
  • Compensation: $949,522
  • Related: $0
  • Other: $1,117,631
Scott Laganga (Evp, State Advocacy)
  • Compensation: $1,171,708
  • Related: $0
  • Other: $372,572
Tracey Merchant (Cfo & Evp, Administration)
  • Compensation: $1,124,704
  • Related: $0
  • Other: $369,597
Robert Zirkelbach Ii (Evp, Public Affairs)
  • Compensation: $1,025,001
  • Related: $0
  • Other: $370,547
Shannon C Monsif (Evp, Advocacy & Strategic All)
  • Compensation: $1,047,384
  • Related: $0
  • Other: $309,960
Anne M Pritchett (Svp, Policy/Research)
  • Compensation: $1,007,339
  • Related: $0
  • Other: $247,782
Jay Taylor (Evp, International)
  • Compensation: $938,748
  • Related: $0
  • Other: $297,850
Kenneth K Mckay Iv (Svp, State Advocacy)
  • Compensation: $892,286
  • Related: $0
  • Other: $277,672
Elizabeth Carpenter (Evp, Policy/Research)
  • Compensation: $440,346
  • Related: $0
  • Other: $335,023
Renuka Iyer (Evp, Human Resources)
  • Compensation: $397,692
  • Related: $0
  • Other: $222,340
Richard Moscicki Md (Cmo & Evp, Science/Reg Advocac)
  • Compensation: $597,574
  • Related: $0
  • Other: $0
Paul A Aines (Cfo & Evp, Administration)
  • Compensation: $581,484
  • Related: $0
  • Other: $0
Robin E Palchus (Svp, Human Resources)
  • Compensation: $289,277
  • Related: $0
  • Other: $0
Vasant Vas Narasimhan Md (Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Daniel O'Day (Vice Chairman)
  • Compensation: $0
  • Related: $0
  • Other: $0
Chris Boerner Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jean-Michel Boers (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Albert Bourla (Treasurer)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert Bradway (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robert M Davis (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Thomas Gibbs (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Barry Greene (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sebastian Guth Phd (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Alexander Hardy (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Herve J Hoppenot (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Ken Keller (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Julie Kim (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Douglas J Langa (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
David Loew (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Bob Lojewski (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Richard F Pops (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Myrtle Potter (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Tarek Rabah (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Mark Reisenauer (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
David Ricks (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Chris Round (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jennifer Taubert (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jean-Christophe Tellier Md (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Chris Viehbacher (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Emma Walmsley (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Tatsuyki Yasuno (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Paul Hudson (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0
Jean-Jaques Bienaime (Director)
  • Compensation: $0
  • Related: $0
  • Other: $0


Official website here: www.phrma.org

Where can I find the form 990 for Pharmaceutical Research And Manufacturers Of America?

Pharmaceutical Research And Manufacturers Of America's most recent form 990 was submitted in 2023 and can be accessed here.


Official website here: www.phrma.org

Learn more at the official website: www.phrma.org

Mission Statement of Pharmaceutical Research And Manufacturers Of America

Pharmaceutical Research and Manufacturers of America (PHRMA) is a prominent organization dedicated to advocating for public policies that encourage the discovery of new medicines for patients by biopharmaceutical research companies. In simple terms, PHRMA acts as an advocate before governmental and regulatory bodies in the US and around the world, promoting policies that support patient access to safe and effective medicines.

The mission of PHRMA is two-fold. First, they advocate for patient access to medicines through a free market, ensuring that prices are not controlled by the government. They believe that strong intellectual property incentives encourage innovation and the development of new treatments. Moreover, they advocate for transparent, efficient regulation and the free flow of information to patients, allowing them to make informed decisions about their health.

Secondly, PHRMA works closely with and on behalf of its member companies to achieve these goals. They are a powerful voice in the pharmaceutical industry, influencing policies that can have a significant impact on the availability and affordability of new medicines for patients. By advocating for policies that support a free market, strong intellectual property incentives, and transparent regulation, PHRMA aims to encourage the discovery and development of new medicines that can improve the lives of patients around the world.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

Pharmaceutical Research and Manufacturers of America (PhRMA) plays a crucial role in shaping public policy to enhance the innovation and accessibility of new medicines. Its advocacy efforts are focused on creating an environment that fosters biopharmaceutical research and development, ensuring that patients have access to safe and effective medications.

By engaging with governmental and regulatory bodies, PhRMA promotes policies that prioritize patient access and innovation. This includes supporting a free market approach that resists government price controls, which can hinder investment in drug discovery. The organization also champions strong intellectual property protections, which incentivize research and development, leading to the discovery of groundbreaking therapies.

Furthermore, PhRMA advocates for transparent and efficient regulatory processes that facilitate the flow of information to patients, ensuring they understand their treatment options. Through these efforts, PhRMA significantly impacts the landscape of pharmaceutical development, working to ensure that advancements benefit patients and meet public health needs.




This information is meant to be a general summary of Pharmaceutical Research And Manufacturers Of America. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$483,040,082 (2023)
Expenses
$426,549,040 (2023)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2023.

  • Investment Income: $13,451,428
  • Program Service Revenue: $467,347,022
  • Gross Receipts: $498,465,949

Assets and Liabilities:

  • Total Assets: $286,234,000
  • Total Liabilities: $134,567,292
  • Net Assets: $151,666,708

Want to help this charity, for free? You can click here to learn more about Give Freely

Programs

Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

MEMBERSHIP DUES

Revenue

$465,244,997

MEETINGS, SECTIONS, STUDIES

Revenue

$2,102,025

Organization Details

Founding Year

1958

Principal Officer

Stephen J Ubl

NTEE Category

Code: S41 - Community improvement

If you are a representative of Pharmaceutical Research And Manufacturers Of America and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.